US5049221055
US5049221055
Labcorp Holdings Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 25.32B EUR | 22.65B EUR | 21.96B EUR | 20.62B EUR |
Enterprise Value | 32.18B EUR | 29.28B EUR | 28.22B EUR | 26.62B EUR |
Valuation Multiples | ||||
Trailing P/E | 25.82x | 22.6x | 23.32x | 31.07x |
Forward P/E | 15.74x | -- | -- | -- |
Price to Sales | 1.76x | 1.58x | 1.55x | 1.94x |
Price to Book | 2.93x | 2.63x | 2.52x | 2.39x |
EV/Revenue | 2.24x | 2.04x | 2x | 2.51x |
EV/EBITDA | 13.87x | 12.93x | 12.98x | 16.32x |
Price to FCF (P/FCF) | 28.38x | 19.61x | 15.87x | 15.7x |
EV/FCF | 36.07x | 25.34x | 20.39x | 20.26x |
FCF Yield | 3.52% | 5.1% | 6.3% | 6.37% |